What do you do when the country you rely on for your life-saving medicines is the one you consider your systemic rival? Every day, many tons of chemicals are churned out in Chinese factories, which ...
The Food and Drug Administration is expected to soon decide if Florida can import cheaper prescription drugs from Canadian ...
Cosmetics sales in China are soaring, but a group of exporting nations led by France are pushing Beijing to lift restrictions they say are blocking them unfairly. By Keith Bradsher and Elizabeth ...
An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said ...
A drug from AstraZeneca Plc and Daiichi Sankyo Co. showed favorable results in a trial for a common type of breast cancer, in a sign it could become a top seller for the British pharmaceutical ...
Sept 15 (Reuters) - (This Sept. 15 story has been corrected show that momelotinib is approved for patients regardless of prior myelofibrosis therapy, not just for patients previously treated ...
Add articles to your saved list and come back to them any time. A drug invented in Melbourne to treat a lethal bone marrow cancer is set to become a billion-dollar global blockbuster after US ...
Have you been paying attention to the news recently? See how many of these 10 questions you can get right. Compiled by Katherine Schulten On TikTok, the term “beige flag” is being used to ...
SYDNEY, Sept. 22 (Xinhua) -- Researchers from Australia's University of Queensland have identified a new drug target that has the potential to overcome drug resistance and prevent tumor regrowth ...
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.
Years of polarizing scientific discourse and bruising online debate will come to a head next week when advisers to the Food and Drug Administration weigh in on NurOwn, a potential treatment to ...
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ...
